This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Get Ready for Value Stock-Picking

Editor's note: This was originally published on RealMoney. It is being republished as a bonus for readers. To subscribe to RealMoney, click here.

Join Jim Cramer, Doug Kass, Helene Meisler and other RealMoney pros at Investment Conference on "Best Ideas to Make Real Money." Save the date: Saturday, May 2! More details here.

The merger wave in pharmaceutical stocks is one of the healthiest things I see going on in the market right now. Monday brought the latest bid, when Merck (MRK - Get Report) announced a $41 billion deal for Schering-Plough (SGP). I have said before that one of the ways to stop a real bear market like we have been experiencing is a merger wave. Stocks reach levels where it is just cheaper to buy assets, earnings, technologies and patents on the stock exchange as opposed to developing them yourself. The pharmas are just the first. I expect the oil and oil service stocks to be the next group to experience a rash of mergers and acquisitions in 2009. Ultimately it will be business acting in the interest of profits that ends the bear market, not government intervention or monetary policy.

I am not making a definitive bottom call; there are still a lot of problems out there. The real estate market still faces pressure from foreclosures and write-offs, and that is probably going to continue for some time. The major banks are a toxic disaster area. The automakers, particularly General Motors (GM - Get Report), are in deep trouble, with no end in sight. Unemployment has not yet peaked; most think we will approach 10% unemployment before it does. There is a very real risk of the broader market continuing to fall for awhile. But stocks and the assets and earnings they represent are getting cheap.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FCY $0.00 0.00%
FCE.A $22.17 0.41%
ESIO $7.05 0.57%
GM $30.54 -0.16%
ADPT $59.28 -3.45%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs